Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.

Thayakaran R, Adderley NJ, Sainsbury C, Torlinska B, Boelaert K, Šumilo D, Price M, Thomas GN, Toulis KA, Nirantharakumar K.

BMJ. 2019 Sep 3;366:l4892. doi: 10.1136/bmj.l4892.

2.

Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.

Lavrentaki A, Thomas T, Subramanian A, Valsamakis G, Thomas N, Toulis KA, Wang J, Daly B, Saravanan P, Sumilo D, Mastorakos G, Tahrani AA, Nirantharakumar K.

J Diabetes Complications. 2019 Oct;33(10):107401. doi: 10.1016/j.jdiacomp.2019.06.006. Epub 2019 Jun 27.

PMID:
31326267
3.

Correction: Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study.

Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K.

PLoS Med. 2019 Jul 18;16(7):e1002881. doi: 10.1371/journal.pmed.1002881. eCollection 2019 Jul.

4.

Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease.

Toulis KA, Viola D, Gkoutos G, Keerthy D, Boelaert K, Nirantharakumar K.

Clin Endocrinol (Oxf). 2019 Aug;91(2):323-330. doi: 10.1111/cen.13990. Epub 2019 May 17.

PMID:
30993728
5.

Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes.

Subramanian A, Adderley NJ, Tracy A, Taverner T, Hanif W, Toulis KA, Thomas GN, Tahrani AA, Nirantharakumar K.

Diabetes Care. 2019 May;42(5):954-963. doi: 10.2337/dc18-2004. Epub 2019 Mar 12.

PMID:
30862657
6.

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study.

Balachandran K, Sumilo D, O'Reilly MW, Toulis KA, Gokhale K, Wijeyaratne C, Coomarasamy A, Arlt W, Tahrani A, Nirantharakumar K.

Eur J Endocrinol. 2019 Feb 1. pii: EJE-18-0693.R2. doi: 10.1530/EJE-18-0693. [Epub ahead of print]

7.

Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis.

Fountas A, Lavrentaki A, Subramanian A, Toulis KA, Nirantharakumar K, Karavitaki N.

J Clin Endocrinol Metab. 2018 Dec 21. doi: 10.1210/jc.2018-01956. [Epub ahead of print]

PMID:
30590584
8.

Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study.

Ntouva A, Toulis KA, Keerthy D, Adderley NJ, Hanif W, Thayakaran R, Gokhale K, Thomas GN, Khunti K, Tahrani AA, Nirantharakumar K.

Eur J Endocrinol. 2019 Jan 1;180(1):51-58. doi: 10.1530/EJE-18-0458.

PMID:
30400051
9.

Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort.

Toulis KA, Jiang CQ, Hemming K, Nirantharakumar K, Cheng KK, Lam TH, Thomas GN.

PLoS One. 2018 Nov 6;13(11):e0206964. doi: 10.1371/journal.pone.0206964. eCollection 2018.

10.

Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort.

O'Reilly MW, Glisic M, Kumarendran B, Subramanian A, Manolopoulos KN, Tahrani AA, Keerthy D, Muka T, Toulis KA, Hanif W, Thomas GN, Franco OH, Arlt W, Nirantharakumar K.

Clin Endocrinol (Oxf). 2019 Jan;90(1):145-154. doi: 10.1111/cen.13862. Epub 2018 Oct 23.

11.

Correction to: Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Diabetologia. 2018 Jul;61(7):1688-1689. doi: 10.1007/s00125-018-4620-4. Epub 2018 Apr 25.

PMID:
29744540
12.

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.

Kumarendran B, O'Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ, Wijeyaratne CN, Coomarasamy A, Arlt W, Nirantharakumar K.

PLoS Med. 2018 Mar 28;15(3):e1002542. doi: 10.1371/journal.pmed.1002542. eCollection 2018 Mar.

13.

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Diabetologia. 2018 May;61(5):1064-1070. doi: 10.1007/s00125-018-4574-6. Epub 2018 Feb 24. Erratum in: Diabetologia. 2018 Apr 25;:.

14.

Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study.

Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K.

PLoS Med. 2018 Jan 16;15(1):e1002488. doi: 10.1371/journal.pmed.1002488. eCollection 2018 Jan. Erratum in: PLoS Med. 2019 Jul 18;16(7):e1002881.

15.

Initiation of dapagliflozin and treatment-emergent fractures.

Toulis KA, Bilezikian JP, Thomas GN, Hanif W, Kotsa K, Thayakaran R, Keerthy D, Tahrani AA, Nirantharakumar K.

Diabetes Obes Metab. 2018 Apr;20(4):1070-1074. doi: 10.1111/dom.13176. Epub 2018 Jan 8.

PMID:
29193543
16.

Males with prolactinoma are at increased risk of incident cardiovascular disease.

Toulis KA, Robbins T, Reddy N, Balachandran K, Gokhale K, Wijesinghe H, Cheng KK, Karavitaki N, Wass J, Nirantharakumar K.

Clin Endocrinol (Oxf). 2018 Jan;88(1):71-76. doi: 10.1111/cen.13498. Epub 2017 Nov 8.

PMID:
29044586
17.

Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.

Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale KM, Balachandran K, Nirantharakumar K.

J Am Coll Cardiol. 2017 Sep 19;70(12):1429-1437. doi: 10.1016/j.jacc.2017.07.763.

18.

Glycated Hemoglobin, Albuminuria and Surrogate Markers of Macrovascular Disease in Adults Without Diabetes: The Guangzhou Biobank Cohort Study, Cardiovascular Disease Subcohort.

Toulis KA, Jiang CQ, Hemming K, Nirantharakumar K, Cheng KK, Lam TH, Thomas GN.

Can J Diabetes. 2018 Jun;42(3):245-250.e1. doi: 10.1016/j.jcjd.2017.06.001. Epub 2017 Jul 6.

PMID:
28689704
19.

All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database.

Toulis KA, Willis BH, Marshall T, Kumarendran B, Gokhale K, Ghosh S, Thomas GN, Cheng KK, Narendran P, Hanif W, Nirantharakumar K.

J Clin Endocrinol Metab. 2017 May 1;102(5):1719-1725. doi: 10.1210/jc.2016-3446.

PMID:
28323967
20.

Galanin in pregnancy: Is there an association with birth weight and gestational diabetes?

Bili E, Karagianni E, Goulis DG, Toulis KA, Grimbizis G, Tarlatzis BC.

J Matern Fetal Neonatal Med. 2017 Dec;30(23):2812-2817. doi: 10.1080/14767058.2016.1263990. Epub 2016 Dec 14. Review.

PMID:
27881034
21.

Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study.

Dafoulas GE, Toulis KA, Mccorry D, Kumarendran B, Thomas GN, Willis BH, Gokhale K, Gkoutos G, Narendran P, Nirantharakumar K.

Diabetologia. 2017 Feb;60(2):258-261. doi: 10.1007/s00125-016-4142-x. Epub 2016 Oct 31.

22.

Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study.

Toulis KA, Nirantharakumar K, Ryan R, Marshall T, Hemming K.

J Clin Endocrinol Metab. 2015 May;100(5):1933-40. doi: 10.1210/jc.2014-3481. Epub 2015 Feb 19.

PMID:
25695881
23.

Cognitive function in Hashimoto's thyroiditis under levothyroxine treatment.

Giannouli V, Toulis KA, Syrmos N.

Hormones (Athens). 2014 Jul-Sep;13(3):430-3. doi: 10.14310/horm.2002.1507.

24.

Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients.

Negro R, Valcavi R, Agrimi D, Toulis KA.

Endocr Pract. 2014 Sep;20(9):901-6. doi: 10.4158/EP13378.OR.

PMID:
24793916
25.

Thyroid cancer after in vitro fertilization: a retrospective, non-consecutive case-series analysis.

Pazaitou-Panayiotou K, Toulis KA, Mandanas S, Tarlatzis BC.

Gynecol Endocrinol. 2014 Aug;30(8):569-72. doi: 10.3109/09513590.2014.907258. Epub 2014 Apr 7.

PMID:
24702193
26.

Maternal subclinical hypothyroidsm and gestational diabetes mellitus: a meta-analysis.

Toulis KA, Stagnaro-Green A, Negro R.

Endocr Pract. 2014 Jul;20(7):703-14. doi: 10.4158/EP13440.RA.

PMID:
24449677
27.

Association of TSH concentrations and thyroid autoimmunity with IVF outcome in women with TSH concentrations within normal adult range.

Mintziori G, Goulis DG, Gialamas E, Dosopoulos K, Zouzoulas D, Gitas G, Venetis CA, Toulis KA, Kolibianakis EM, Tarlatzis BC.

Gynecol Obstet Invest. 2014;77(2):84-8. doi: 10.1159/000357193. Epub 2013 Dec 14.

PMID:
24356283
28.

Thyrotropin receptor autoantibodies and early miscarriages in patients with Hashimoto thyroiditis: a case-control study.

Toulis KA, Goulis DG, Tsolakidou K, Hilidis I, Fragkos M, Polyzos SA, Gerofotis A, Kita M, Bili H, Vavilis D, Daniilidis M, Tarlatzis BC, Papadimas I.

Gynecol Endocrinol. 2013 Aug;29(8):793-6. doi: 10.3109/09513590.2013.801449. Epub 2013 Jun 6.

PMID:
23741968
29.

Thyrotropin values in patients with micropapillary thyroid cancer versus benign nodular disease.

Negro R, Valcavi R, Riganti F, Toulis KA, Colosimo E, Bongiovanni M, Grassi P, Giovanella L, Gardini G, Piana S.

Endocr Pract. 2013 Jul-Aug;19(4):651-5. doi: 10.4158/EP12385.OR.

PMID:
23512387
30.

Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.

Negro R, Valcavi R, Toulis KA.

Endocr Pract. 2013 Mar-Apr;19(2):212-8. doi: 10.4158/EP12234.OR.

PMID:
23186976
32.

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab.

Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P.

Ther Clin Risk Manag. 2012;8:295-306. doi: 10.2147/TCRM.S24239. Epub 2012 Jun 19.

33.

Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis.

Toulis KA, Anastasilakis AD, Polyzos SA, Makras P.

Hormones (Athens). 2011 Jul-Sep;10(3):174-95. Review.

34.

Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.

Anastasilakis AD, Polyzos SA, Toulis KA.

Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):383-8. doi: 10.1097/MED.0b013e32834afff2. Review.

PMID:
21897222
35.

Thyroid function during ovarian stimulation: a systematic review.

Mintziori G, Goulis DG, Toulis KA, Venetis CA, Kolibianakis EM, Tarlatzis BC.

Fertil Steril. 2011 Sep;96(3):780-5. doi: 10.1016/j.fertnstert.2011.06.020. Epub 2011 Jul 13. Review.

PMID:
21742326
36.

The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.

Pontikis C, Yavropoulou MP, Toulis KA, Kotsa K, Kazakos K, Papazisi A, Gotzamani-Psarakou A, Yovos JG.

J Womens Health (Larchmt). 2011 Jun;20(6):971-6. doi: 10.1089/jwh.2010.2272.

PMID:
21671782
37.

Evaluation of dietary habits and assessment of cardiovascular disease risk factors among Greek university students.

Chourdakis M, Tzellos T, Pourzitaki C, Toulis KA, Papazisis G, Kouvelas D.

Appetite. 2011 Oct;57(2):377-83. doi: 10.1016/j.appet.2011.05.314. Epub 2011 May 27.

PMID:
21651931
38.

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.

Toulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, Poulasouchidou M, Tzellos TG, Makedos A, Chourdakis M, Tarlatzis BC.

Hum Reprod Update. 2011 Nov-Dec;17(6):741-60. doi: 10.1093/humupd/dmr025. Epub 2011 May 30.

PMID:
21628302
39.

Apelin levels in normal pregnancy.

Kourtis A, Gkiomisi A, Mouzaki M, Makedou K, Anastasilakis AD, Toulis KA, Gerou S, Gavana E, Agorastos T.

Clin Endocrinol (Oxf). 2011 Sep;75(3):367-71. doi: 10.1111/j.1365-2265.2011.04061.x.

PMID:
21521329
40.

Oxidized low-density lipoprotein and adiponectin levels in pregnancy.

Makedou K, Kourtis A, Gkiomisi A, Toulis KA, Mouzaki M, Anastasilakis AD, Gerou S, Gavana E, Agorastos T.

Gynecol Endocrinol. 2011 Dec;27(12):1070-3. doi: 10.3109/09513590.2011.569793. Epub 2011 Apr 19.

PMID:
21504339
41.

Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis.

Anastasilakis AD, Polyzos SA, Anastasilakis CD, Toulis KA, Makras P.

Med Hypotheses. 2011 Jul;77(1):109-11. doi: 10.1016/j.mehy.2011.03.039. Epub 2011 Apr 8.

PMID:
21482033
42.

Serum vaspin levels in normal pregnancy in comparison with non-pregnant women.

Giomisi A, Kourtis A, Toulis KA, Anastasilakis AD, Makedou KG, Mouzaki M, Gerou S, Gavana E, Agorastos T, Giannoulis C.

Eur J Endocrinol. 2011 Apr;164(4):579-83. doi: 10.1530/EJE-10-1020. Epub 2011 Jan 31.

PMID:
21282352
43.

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J.

Metabolism. 2011 Mar;60(3):313-26. doi: 10.1016/j.metabol.2010.09.003. Epub 2010 Oct 30. Review.

PMID:
21040935
44.

Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis.

Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D.

Thyroid. 2010 Oct;20(10):1163-73. doi: 10.1089/thy.2009.0351. Review.

PMID:
20883174
45.

Inhibin B and anti-Mullerian hormone as markers of persistent spermatogenesis in men with non-obstructive azoospermia: a meta-analysis of diagnostic accuracy studies.

Toulis KA, Iliadou PK, Venetis CA, Tsametis C, Tarlatzis BC, Papadimas I, Goulis DG.

Hum Reprod Update. 2010 Nov-Dec;16(6):713-24. doi: 10.1093/humupd/dmq024. Epub 2010 Jul 1. Review.

PMID:
20601364
46.

Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis.

Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Papadimas I, Tarlatzis BC.

Fertil Steril. 2011 Jan;95(1):188-96, 196.e1-3. doi: 10.1016/j.fertnstert.2010.05.026. Epub 2010 Jul 1. Review.

PMID:
20579987
47.

Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis.

Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Negro R, Tarlatzis BC, Papadimas I.

Eur J Endocrinol. 2010 Apr;162(4):643-52. doi: 10.1530/EJE-09-0850. Epub 2009 Dec 2. Review.

PMID:
19955261
48.

The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.

Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E.

Clin Endocrinol (Oxf). 2010 Jun;72(6):752-7. doi: 10.1111/j.1365-2265.2009.03728.x. Epub 2009 Oct 15.

PMID:
19832854
49.

RANKL inhibition for the management of patients with benign metabolic bone disorders.

Anastasilakis AD, Toulis KA, Polyzos SA, Terpos E.

Expert Opin Investig Drugs. 2009 Aug;18(8):1085-102. doi: 10.1517/13543780903048929. Review.

PMID:
19558335
50.

Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis.

Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Tarlatzis BC, Papadimas I.

Med Hypotheses. 2009 Dec;73(6):1060-2. doi: 10.1016/j.mehy.2009.05.012. Epub 2009 Jun 7.

PMID:
19505771

Supplemental Content

Loading ...
Support Center